Back to results
US 10,017,507 B2Granted
Diaza-benzofluoranthrene compounds
AssigneeHarbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory
InventorsShujie Yuan, Xinchun Yang, Jinlong Zhao, Daoxu Zhang, Mingda Sun, Jiaji Liu, Tao Wei, Huanan Zhao, Yunfu Luo, Chundao Yang
Life of this patent
Estimating the term…
Abstract
Disclosed are a series of diaza-benzofluoranthrene compounds. The present invention particularly relates to a compound represented by formula (I), pharmaceutically acceptable salts or tautomers thereof.
Claims18
A compound of formula (I), or a pharmaceutically acceptable salt or a tautomer thereof,
- wherein:
- R1 and R3 are separately and independently selected from H;
- or
- R1 and R3 are separately and independently selected from the group, optionally substituted by R01, consisting of
- S(═O)2NH2 or C1-4 alkyl;
- R2 is selected from
- wherein:
- from zero to two of T21-23 is N, and the rest is C(Rt);
- D21 is selected from—C(Rd1)(Rd2)—, —C(═O)N(Rd3)—, —N(Rd4)—, —C(═NRd5)—, —S(═O)2N(Rd6)—, —S(═O)N(Rd7)—, —O—, —S—, —C(═O)O—,—C(═O)-,—C(═S)-, —S(═O)—, —S(═O)2— or —N(Rd8)C(═O)N(Rd9)—;
- T24 is selected from N or C(Rt);
- D22-24 are separately and independently selected from —C(Rd1)(Rd2)—, —C(═O)N(Rd3)—, —N(Rd4)—, —C(═NRd5)—, —S(═O)2N(Rd6)—, —S(═O)N(Rd7)—, —O—, —S—, —C(═O)O—, —C(═O)—, —C(═S)—, —S(═O)—, —S(═O)2— or —N(Rd8)C(═O)N(Rd9)—;
- from zero to two of T25-29 is N, and the rest is C(Rt);
- optionally, any two of Rt and Rd1-d9 are bonded to a common atom or group together to form one or two 3- to 8-membered rings;
- Rt, Rd1 and Rd2 are separately and independently selected from H, F, Cl, Br, I, CN, OH, SH, NH2, CHO, COOH, C(═O)NH2, S(═O)NH2, or S(═O)2NH2;
- or
- Rt, Rd1 and Rd2 are separately and independently selected from the group, optionally substituted by R01, consisting of C1-10 alkyl, C1-10 alkyl heteroalkyl, C3-10 cyclic hydrocarbyl, or C3-10 heterocyclic hydrocarbyl, C1-10 alkyl substituted by C3-10 cyclohydrocarbyl or C3-10 heterocyclohydrocarbyl, C1-10 heteroalkyl substituted by C3-10 cyclohydrocarbyl or C3-10 heterocyclohydrocarbyl, C1-10 alkenyl, and C1-10 heteroalkenyl;
- R01 is selected from F, Cl, Br, I, CN, OH, SH, NH2, CHO, COOH, C(═O)NH2, S(═O)NH2, S(═O)2NH2 or R02;
- R02 is selected from C1-10 alkyl, C1-10 heteroalkyl, C3-10 cycloalkyl, C3-10 heterocyclic alkyl, aminoacyl, or a 5- to 12-membered unsaturated heterocyclic group;
- “hetero-” represents a hetero atom or a hetero atom-containing group, which is selected from the group consisting of —C(═O)N(Rd3)—, —N(Rd4)—, —C(═NRd5)—, —S(═O)2N(Rd6)−, —S(═O)N(Rd7)—, —O—, —S—, ═O, ═S, —C(═O)O—, —C(═O)—, —C(═S)—, —S(═O)—, —S(═O)2— and —N(Rd8)C(═O)N(Rd9)—;
- Rd3-d9 are separately and independently selected from H, NH2, or R02;
- R02 is optionally substituted by R001;
- R001 is selected from F, Cl, Br, I, CN, OH, N(CH3)2, NH(CH3), NH2, CHO, COOH,
- C(═O)NH2, S(═O)NH2, S(═O)2NH2, trifluoromethyl, aminomethyl, hydroxymethyl, methyl, methoxy, formyl, methoxycarbonyl, methanesulfonyl, or methylsulfinyl;
- the number of R01, R001, the hetero atom or the hetero atom-containing group are separately and independently selected from 0, 1, 2, 3, or 4.
21 more elements
Dependencies are inferred from the claim text.